Atlas Trials

Clinical Study to Evaluate the Safety and Feasibility of spCART-269 Injection in the Treatment of MM

Clinical trial NCT04500431 · UNKNOWN

Trial details

NCT number
NCT04500431
Sponsor
Shanghai Tongji Hospital, Tongji University School of Medicine
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2018-07-01
Primary completion
2022-07-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.